The lack of data and research on the potential neuroprotection of lactoferrin against Parkinson’s disease offers a very wide field of study in the search for an alternative that could be, in the future, a safe and effective therapeutic option to manage brain anomalies and movement disorders associated with PD [69]. This evidence concerns the gene LTF and Parkinson disease.